VOYA Investment Management
DAWN

VOYA Investment Management’s Day One Biopharmaceuticals DAWN Stock Holding History

VOYA Investment Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$284K Hold
13,242
– – ﹤0.01% 1975
2025
Q4 		$123K Hold
13,242
– – ﹤0.01% 2233
2025
Q3 		$93.4K Sell
13,242
-6,373
-32% -$43.8K ﹤0.01% 2312
2025
Q2 		$127K Buy
19,615
+5,140
+36% +$35.4K ﹤0.01% 2430
2025
Q1 		$115K Sell
14,475
-1,326
-8% -$14.3K ﹤0.01% 2409
2024
Q4 		$200K Sell
15,801
-1,648
-9% -$22.9K ﹤0.01% 2396
2024
Q3 		$243K Sell
17,449
-18,340
-51% -$262K ﹤0.01% 2371
2024
Q2 		$493K Sell
35,789
-2,409
-6% -$35.2K ﹤0.01% 2009
2024
Q1 		$631K Sell
38,198
-4,673
-11% -$69.9K ﹤0.01% 1894
2023
Q4 		$626K Buy
42,871
+298
+0.7% +$3.61K ﹤0.01% 1951
2023
Q3 		$522K Buy
42,573
+5,786
+16% +$75.5K ﹤0.01% 2016
2023
Q2 		$439K Buy
36,787
+8,889
+32% +$116K ﹤0.01% 2156
2023
Q1 		$373K Hold
27,898
– – ﹤0.01% 2207
2022
Q4 		$600K Hold
27,898
– – ﹤0.01% 1925
2022
Q3 		$559K Buy
+27,898
New +$593K ﹤0.01% 1959

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

VOYA Investment Management's DAWN Position: Q1 2026 in Review

VOYA Investment Management held its Day One Biopharmaceuticals (DAWN) position steady in Q1 2026 at 13,242 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #1975.

VOYA Investment Management first reported a position in DAWN in Q3 2022 and has held it in 15 quarters since. The position peaked at $631K in Q1 2024. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • VOYA Investment Management held 13,242 shares of Day One Biopharmaceuticals worth $284K as of Q1 2026.
  • VOYA Investment Management left its Day One Biopharmaceuticals share count unchanged in Q1 2026.
  • Day One Biopharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1975 holding.
  • VOYA Investment Management first reported a position in Day One Biopharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • VOYA Investment Management's Day One Biopharmaceuticals position peaked at $631K in Q1 2024.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.